Cargando…
Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy
In addition to promoting various forms of cell death, most conventional anti-tumor therapies also promote senescence. There is now extensive evidence that therapy-induced senescence (TIS) might be transient, raising the concern that TIS could represent an undesirable outcome of therapy by providing...
Autores principales: | Saleh, Tareq, Tyutynuk-Massey, Liliya, Cudjoe, Emmanuel K., Idowu, Michael O., Landry, Joseph W., Gewirtz, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968105/ https://www.ncbi.nlm.nih.gov/pubmed/29868482 http://dx.doi.org/10.3389/fonc.2018.00164 |
Ejemplares similares
-
Studies of Non-Protective Autophagy Provide Evidence that Recovery from Therapy-Induced Senescence is Independent of Early Autophagy
por: Saleh, Tareq, et al.
Publicado: (2020) -
Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐X(L)–BAX interaction
por: Saleh, Tareq, et al.
Publicado: (2020) -
Cell senescence, the senescence-associated secretory phenotype, and cancers
por: Langhi Prata, Larissa G. P., et al.
Publicado: (2023) -
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
por: Saleh, Tareq, et al.
Publicado: (2020) -
Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease
por: Wang, Wen-Juan, et al.
Publicado: (2017)